Company Overview and News


Add 500126
to your dashboard

Headline News

Stereochemical Mysteries, Solved

2017-11-28 seekingalpha
Ask a chemist (I'll do) about optical rotation, and you'll get a confident answer about how right- and left-handed isomers of chiral compounds will rotate polarized light that shines through a solution of one of them. Ask one of us exactly how it does that, and in 99 cases out of a hundred, you'll witness a hurried change of the subject or a nervous admission that they have no actual idea. The phenomenon is well-known to us chemists, but the deeper explanation is even worse than NMR; you step off into a deep physics hole (by chemist standards) rather quickly. (4-0)

Tracking Kahn Brothers Portfolio - Q3 2017 Update

2017-11-05 seekingalpha
The portfolio continues to be very concentrated, with the top five positions accounting for ~45% of the 13F holdings. (429-3)

Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2017 Update

2017-10-20 seekingalpha
Alibaba Group Holdings, Amazon.com, Visa Inc., Apple Inc., and Johnson & Johnson are the largest five individual stock positions. (1097-4)

Merck Limited - Trading Window

2017-09-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (19-0)

RXi Pharmaceuticals' (RXII) CEO Dr. Geert Cauwenbergh on Q2 2017 Results - Earnings Call Transcript

2017-08-11 seekingalpha
Good day, ladies and gentlemen and welcome to today’s webcast entitled RXi Pharmaceuticals Second Quarter 2017 Financial Results Conference Call. Today’s call is being recorded.

Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates in Revised Collaboration

2017-08-10 genengnews
Celgene has ended its option to acquire Sutro Biopharma in return for gaining full global rights to a second Sutro preclinical program, and outside-U.S. rights to two others in a reworking of the companies’ immuno-oncology collaboration, whose value was not disclosed.

Tracking Kahn Brothers Portfolio - Q2 2017 Update

2017-08-09 seekingalpha
The portfolio continues to be very concentrated with the top five positions accounting for ~43% of the 13F holdings.

Fresenius' (FSNUY) CEO Stephan Sturm on Q2 2017 Results - Earnings Call Transcript

2017-08-02 seekingalpha
Fresenius SE & Co. KGaA ADR (OTCQX:FSNUY) Q2 2017 Results Earnings Conference Call August 1, 2017 8:00 AM ET

Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2017 Update

2017-07-24 seekingalpha
Amazon.com, Johnson & Johnson, Apple Inc., Visa Inc., and Alibaba Group Holdings are the largest five individual stock positions.

Merck Limited - Results

2017-07-21 feedproxy.google

PDS Announces Clinical Collaboration with Merck

2017-07-10 londonstockexchange
London, UK - July 10th 2017 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic IP commercialisation group focused on healthcare, announces a new clinical trial collaboration agreement between its portfolio company PDS Biotechnology Corporation ("PDS") and a subsidiary of Merck & Co., Inc. (known as MSD outside the United States and Canada). The agreement will enable PDS to evaluate the combination of its Versamune®-based PDS0101 immunotherapy treatment with Merck & Co.

Merck says new type of cholesterol drug reduces risks

2017-06-27 sfgate
Merck & Co. said Tuesday that a new type of cholesterol drug reduced heart attacks, deaths and other complications of heart disease in a huge, late-stage study.

Merck Limited - Shareholders meeting

2017-06-22 feedproxy.google

Merck Limited - Trading Window

2017-06-16 feedproxy.google

Merck Limited - Financial Results Updates

2017-05-19 feedproxy.google